President Trump announced that all 50 states will participate in his administration's "most-favored-nation" program aimed at reducing drug prices. The White House estimates federal and state governments will save $64.3 billion from this initiative, but health policy experts are skeptical about the actual benefits for consumers, especially Medicaid patients who already pay low prices for medications. Experts like…
Health wonks question who saves in Trump drug program (this article)2 articles from Semafor on this story
